How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

Patient Advocay in Rheumatology - A Patient Story

Keck School of Medicine of USC

C. Ames

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Year in Review: zOS Update Version 20.24.Z

Dermatology 2024 Year in Review

M. Zirwas

TBC vs CBD in Rheumatoid Arthritis Patients: What Is The Latest Clin…

Daniel Arkfeld

Methotrexate and the Gut Microbiome

RheumNow

R. Blank

Day 4 Recap: ACR Convergence 2024 Highlights

RheumNow

J. Pope, D. Liew, A. Sood

Practical Practice Pearls

Stephen Stone

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

EULAR® 2024 Insights - Factors Associated with the Evolution of Dege…

EULAR® 2024 Insights

L. Pina Vegas

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Why Are Comorbidites Important in Dermatology? Hear The Answer From …

dermsquared

J. Del Rosso, J. M. Gelfand

Top Shoulder Problems You See in the Office

UCSF School of Medicine

B. Feeley

Difficult to Manage AxSpA

RheumNow

D. Poddubnyy

USSONAR Rheumatology Ultrasound Case Series: Rheumatoid Arthritis an…

USSONAR

J. Yinh

EADV 2024 Insights: High Induction Dosing in Psoriasis: KNOCKOUT Pha…

EADV 2024 Insights

A. Blauvelt

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

Interstitial Lung Disease in RA: RA-ILD Subtypes, Mortality Risk, RA…

RheumNow

J. Sparks, J. Cush

The Microbiome and Psoriasis

International Psoriasis Council (IPC)

W. Liao

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush